Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00229
|
|||||
Drug Name |
Ochratoxin A
|
|||||
Synonyms |
(-)-N-((5-Chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenylalanine; 303-47-9; 3R14S-OCHRATOXIN A; Antibiotic 9663; C20H18ClNO6; CHEBI:7719; N-(((3R)-5-Chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenyl-L-alanine; NCI-C56586; NSC 201422; OTA; Ochratoxin A; Ochratoxin A, aspergillus ochraceus; Ochratoxin A-BSA conjugate from Aspergillus ochraceus; Phenylalanine - ochratoxin A; RWQKHEORZBHNRI-BMIGLBTASA-N; UNII-1779SX6LUY
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Discovery agent [ICD11:N.A.] | Investigative | ||||
Structure |
|
![]() |
||||
3D MOL | 2D MOL | |||||
Formula |
C20H18ClNO6
|
|||||
Canonical SMILES |
CC1CC2=C(C=C(C(=C2C(=O)O1)O)C(=O)NC(CC3=CC=CC=C3)C(=O)O)Cl
|
|||||
InChI |
InChI=1S/C20H18ClNO6/c1-10-7-12-14(21)9-13(17(23)16(12)20(27)28-10)18(24)22-15(19(25)26)8-11-5-3-2-4-6-11/h2-6,9-10,15,23H,7-8H2,1H3,(H,22,24)(H,25,26)/t10-,15+/m1/s1
|
|||||
InChIKey |
RWQKHEORZBHNRI-BMIGLBTASA-N
|
|||||
CAS Number |
CAS 303-47-9
|
|||||
Pharmaceutical Properties | Molecular Weight | 403.8 | Topological Polar Surface Area | 113 | ||
Heavy Atom Count | 28 | Rotatable Bond Count | 5 | |||
Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 6 | |||
XLogP |
4.7
|
|||||
PubChem CID | ||||||
PubChem SID |
10299065
,103724058
,104627857
,11120179
,11120667
,11121155
,11147262
,118696750
,12141
,124892384
,134350815
,135697901
,137023330
,143857343
,162222995
,16490396
,170481060
,178101387
,184581817
,198986655
,224840091
,226405585
,241182305
,24712295
,24860804
,24870560
,24897954
,24897972
,26755747
,26755748
,3139649
,36886052
,47662027
,47736217
,48334225
,48334226
,48414248
,48423859
,49759540
,49855309
,50111288
,53790274
,56310922
,56312193
,56313137
,56313924
,57649028
,74764013
,85844004
,88782767
|
|||||
ChEBI ID |
CHEBI:7719
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | ABCA8 | Transporter Info | ATP-binding cassette sub-family A member 8 | Substrate | [1] | |
OAT1 | Transporter Info | Organic anion transporter 1 | Substrate | [2] | ||
OAT3 | Transporter Info | Organic anion transporter 3 | Substrate | [2] | ||
OAT4 | Transporter Info | Organic anion transporter 4 | Substrate | [3] | ||
Drug-Transporter Activity Data | ||||||
Drug-Transporter Activity Data | ABCA8 | Transporter Info | Km =0.4 microM | Xenopus laevis oocytes-ABCA8 | [1] | |
OAT1 | Transporter Info | Km =0.42 microM | Proximal tubule (S2) cells-OAT1 | [2] | ||
OAT3 | Transporter Info | Km =0.75 microM | Proximal tubule (S2) cells-OAT3 | [2] | ||
OAT4 | Transporter Info | Km =22.9 microM | Proximal tubule (S2) cells-OAT4 | [3] | ||
References | ||||||
1 | Functional analysis of ABCA8, a new drug transporter. Biochem Biophys Res Commun. 2002 Oct 18;298(1):41-5. | |||||
2 | Characterization of ochratoxin A transport by human organic anion transporters. Life Sci. 2001 Sep 21;69(18):2123-35. | |||||
3 | Role of human organic anion transporter 4 in the transport of ochratoxin A. Biochim Biophys Acta. 2002 Jun 12;1590(1-3):64-75. |
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.